Hypera S.A. (ADR)
General ticker "HYPMY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.8B (TTM average)
Hypera S.A. (ADR) follows the US Stock Market performance with the rate: 14.6%.
Estimated limits based on current volatility of 2.3%: low 4.57$, high 4.79$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-04-06, amount 0.05$ (Y4.30%)
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.19$, 5.68$]
- 2026-12-31 to 2027-12-31 estimated range: [3.40$, 5.96$]
Financial Metrics affecting the HYPMY estimates:
- Positive: with PPE of 12.3 at the end of fiscal year the price was very low
- Positive: Operating cash flow per share per price, % of 17.63 > 12.96
- Positive: Operating profit margin, % of 22.57 > 18.52
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 4.54
- Positive: Inventory ratio change, % of 0.60 <= 0.80
- Positive: 42.60 < Shareholder equity ratio, % of 49.77 <= 64.25
- Negative: Industry inventory ratio change (median), % of 0.52 > 0.31
Short-term HYPMY quotes
Long-term HYPMY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | BRL7,914.66MM | BRL7,442.47MM | BRL7,699.16MM |
| Operating Expenses | BRL5,629.41MM | BRL5,646.70MM | BRL5,961.11MM |
| Operating Income | BRL2,285.25MM | BRL1,795.77MM | BRL1,738.05MM |
| Non-Operating Income | BRL-775.77MM | BRL-816.53MM | BRL-837.98MM |
| Interest Expense | BRL1,349.52MM | BRL971.05MM | BRL1,043.67MM |
| R&D Expense | BRL189.76MM | BRL145.53MM | BRL134.73MM |
| Income(Loss) | BRL1,509.47MM | BRL979.24MM | BRL900.07MM |
| Taxes | BRL-141.64MM | BRL-353.76MM | BRL-290.75MM |
| Profit(Loss)* | BRL1,647.96MM | BRL1,340.99MM | BRL1,195.37MM |
| Stockholders Equity | BRL11,504.12MM | BRL12,096.28MM | BRL12,522.03MM |
| Inventory | BRL2,191.73MM | BRL1,938.60MM | BRL2,079.18MM |
| Assets | BRL24,508.75MM | BRL24,559.08MM | BRL25,158.00MM |
| Operating Cash Flow | BRL2,395.99MM | BRL2,539.60MM | BRL2,574.43MM |
| Capital expenditure | BRL812.71MM | BRL772.27MM | BRL799.36MM |
| Investing Cash Flow | BRL-791.19MM | BRL-592.44MM | BRL-689.50MM |
| Financing Cash Flow | BRL-1,886.38MM | BRL-2,788.73MM | BRL-1,978.71MM |
| Earnings Per Share** | BRL2.58 | BRL2.12 | BRL1.89 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.